About Swara Baby Products IPO
Swara Baby Products IPO Details
Swara Baby Products IPO is a book-built issue aggregating up to ₹1,000 crore, comprising a fresh issue of equity shares worth ₹500 crore and an offer for sale (OFS) worth ₹500 crore by existing shareholders. The company filed its Draft Red Herring Prospectus (DRHP) with SEBI in early July 2026. The price band and official dates for subscription and listing will be announced later, but the shares are proposed to be listed on the NSE and BSE. Under the OFS, BrainBees Solutions will offload shares worth ₹300 crore, while Anadya Bon Merchari LLP will sell shares worth ₹200 crore. The book-running lead managers for the issue are [.] and the registrar to the issue is [.].
Swara Baby Products IPO Date & Timeline
The Swara Baby Products IPO is officially set to open for subscription on [.] and will close on [.]. The company filed its Draft Red Herring Prospectus (DRHP) with SEBI on July 6, 2026 and has now initiated the regulatory review process. Once the subscription window closes, allotment is expected on [.]. Following this, the firm will initiate refunds and credit shares to the demat accounts of successful investors on [.]. Finally, shares of Swara Baby Products Limited are tentatively scheduled to list on the stock exchanges on [.].
Swara Baby Products IPO Timeline
| IPO Open Date | - |
| IPO Close Date | - |
| Basis of Allotment | - |
| Initiation of Refunds | - |
| Credit of Shares to Demat | - |
| Listing Date | - |
| Cut-off time for UPI mandate confirmation | - |
Swara Baby Products IPO Details
| Detail | Description |
|---|---|
| IPO Date | - |
| Listing Date | - |
| Face Value | ₹ 2 per share |
| Issue Price Band | - |
| Lot Size | - |
| IPO Type | Fresh Issue + Offer For Sale |
| Total Issue Size | [.] shares (agg. up to ₹ 1,000 Cr) |
| Reserved for Market Maker | - |
| Fresh Issue(Ex Market Maker) | [.] shares (agg. up to ₹ 500 Cr) |
| Offer for Sale | [.] shares of ₹2 (agg. up to ₹ 500 Cr) |
| Net Offered to Public | - |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 24,42,84,747 shares |
| Share Holding Post Issue | - |
Swara Baby Products IPO GMP
“Grey Market Premium” (GMP) is the premium at which IPO shares are traded in the grey market before they are officially listed on the stock exchange.
The Swara Baby Products IPO GMP is currently trading at ₹[.], reflecting unofficial investors' sentiment ahead of the official listing. This premium suggests a potential listing price of ₹[.], which is [.]% above the issue price. While the Grey Market Premium is a key indicator of demand and investor appetite, it is important to remember that GMP is highly volatile and should not be the sole factor in your investment decisions.
Company Background
Swara Baby Products Limited is the manufacturing unit of BrainBees Solutions, the parent company that owns FirstCry, and belongs to the category of disposable hygiene products. The DRHP indicates that Swara Baby is a hygiene company serving the baby and adult categories, and that the purpose of the issue is to help expand its independent business. Swara Baby Products IPO is important because the FirstCry ecosystem is already listed on stock exchanges.
Operations & Product Range
The company manufactures disposable hygiene products and has been described as producing diapers, baby apparel and hygiene products for the FirstCry platform as well as for third-party brands. Its business is not limited to baby care; public reports also highlight adult nappies as an important category within its portfolio. That makes Swara Baby a broader hygiene manufacturing play rather than just a baby products story, which may matter to investors evaluating category diversification.
Facilities & Capacity
A notable part of the company’s expansion plan is a new manufacturing plant in Pithampur, Madhya Pradesh, for which about ₹198.2 crore has been earmarked. This planned capacity addition aligns with the broader use-of-funds narrative of expansion and suggests that the company is preparing for larger-scale production in hygiene categories. The final prospectus should provide more granular details on existing plant footprint, installed capacity, utilisation and capex timelines.
Brands & Market Presence
Swara Baby Products is reported to be the largest contract manufacturer of disposable hygiene products in India, by value, in FY25. According to reports, it had a 37% market share in contract manufacturing of baby nappies and a 36% market share in contract manufacturing of adult nappies in India, indicating its presence in both infant and adult hygiene segments. Its association with the FirstCry ecosystem must provide it with a significant channel for demand.
Revenue Streams & Business Model
Swara Baby Products appears to operate primarily as a manufacturing-led business, generating revenue from producing disposable hygiene products for baby and adult care and supplying both the FirstCry platform and third-party brands. This model can create a mix of captive demand and external customer demand, which is useful because it reduces reliance on a single route-to-market. For investors, the key business question is whether this contract-manufacturing scale can translate into durable margins as the company expands capacity and product breadth.
Financial Performance
For FY26, public reports indicated revenue of ₹11,639 million, which is about ₹1,163.9 crore. The same reports said consolidated EBITDA stood at ₹1,445.7 million, or about ₹144.6 crore, showing that the business had already achieved a meaningful operating earnings base ahead of the IPO. While the public summaries cited here do not spell out the final PAT figure, the reported revenue scale and EBITDA profile suggest that Swara Baby enters the market with a more manufacturing-oriented financial profile than many consumer-tech IPO candidates.
Management & Shareholding
The public summaries available here focus more on parent-linkage and selling shareholders than on a full promoter or management table. BrainBees Solutions, the FirstCry parent, has been identified as a key selling shareholder in the OFS and Anadya Bon Merchari LLP is also part of the offer-for-sale structure. A detailed pre-IPO and post-IPO shareholding breakup, promoter classification, and board composition should be included in the DRHP and final RHP once those details are fully available in compiled form.
Board & Key Management
Swara Baby Products is led by Alok Birla, who serves as the Managing Director of the company. The board also includes Supam Maheshwari, Sangita Birla, Gautam Sharma, and Prashant Jadhav as directors. Apart from this, Supam Maheshwari and Gautam Sharma are non-executive directors on the board. Among key managerial personnel, Tushar Gunjalkar is listed as the Company Secretary
Swara Baby Products IPO Financial Information
Latest Revenue
1,163.90
₹ Crore
Profit After Tax
95.59
₹ Crore
Net Worth
553.22
₹ Crore
Total Borrowing
443.06
₹ Crore
| Period Ended | Assets | Revenue From Operations | Profit After Tax | Net Worth | Reserves & Surplus | Total Borrowing | |||
|---|---|---|---|---|---|---|---|---|---|
| 31 Mar 2026 | 1,368.20 | 1,163.90 | 95.59 | 553.22 | 504.58 | 443.06 | |||
| 31 Mar 2025 | 1,002.31 | 942.97 | 80.67 | 399.92 | 367.25 | 354.82 | |||
| 31 Mar 2024 | 780.15 | 749.96 | 93.97 | 319.36 | 286.58 | 260.08 | |||
| Amount in ₹ Crore | |||||||||
Swara Baby Products Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 10.58 % |
| ROCE | 14.48 % |
| Debt/Equity | 10.12 |
| RoNW | 17.28 % |
| PAT Margin | 8.21 % |
| EBITDA Margin | 16.56 % |
| Price to Book Value | - |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 3.91 | - |
| P/E (x) | - | - |
IPO Objectives
The fresh issue proceeds are expected to be used for capacity expansion, debt repayment and acquisitions. More specifically, public reporting indicates that around ₹198.2 crore is earmarked for a new manufacturing facility in Pithampur, Madhya Pradesh, suggesting that a major part of the capital raise is linked to physical scale-up. From an equity-market perspective, this is important because it makes the issue partly a growth-capex story and partly a balance-sheet and strategic-expansion story.
Swara Baby Products IPO Review
Swara Baby Products is positioned in the baby care products, hygiene manufacturing, and contract manufacturing segments, which could be an interesting proposition in the Indian market, where distribution and manufacturing valuations tend to differ. The company's dominance in contract manufacturing terms of revenue in FY25 and in market share for baby and adult diapers makes Swara a player with a scale advantage, which could attract investors looking for a manufacturing-led consumer business rather than a brand-led one. The FY26 revenue base of approximately ₹1,163.9 crore and EBITDA of approximately ₹144.6 crore also make the business much more concrete than most other early-stage consumer businesses.
However, it would be important for investors to focus on margin sustainability, customer concentration, volatile raw materials, reliance on the growth of the category and ultimately valuation at the offer price. This becomes pertinent since contract manufacturing can be highly scale-driven but also carries margin risks.
Conclusion
Swara Baby Products IPO gives investors exposure to a scaled disposable hygiene manufacturer with leadership in India’s contract-manufacturing segments for baby nappies and adult nappies, backed by the broader FirstCry ecosystem. The company enters the public market with a reported FY26 revenue base of about ₹1,163.9 crore and consolidated EBITDA of about ₹144.6 crore, while the fresh issue is intended to support expansion, debt repayment, acquisitions and a new manufacturing facility in Pithampur, Madhya Pradesh.
Overall, Swara Baby Products appears to be a manufacturing-led consumer play with category-scale potential, but investors should closely monitor pricing and execution before making a final call.
Frequently Asked Questions
Recommended Advisory Services
Ready to take your company public? Explore our specialized IPO advisory services tailored for Indian enterprises.
The India IPO Publication is managed by an editorial team that includes highly experienced finance journalists, market researchers and professionals from the capital markets industry who strive to create high-quality content based on credible sources. Our editors write about IPOs, capital markets, corporate news, capital-raising strategies, regulations and other business matters to ensure our audience stays updated with the latest information. We conduct detailed research and fact-check all information before publishing any content to ensure credibility.
Competitive Strengths
India’s largest contract manufacturer of disposable hygiene products by value in FY25.
Strong category position with 37% share in baby nappies contract manufacturing and 36% share in adult nappies contract manufacturing in India.
Backing from the FirstCry ecosystem, with manufacturing support for the platform as well as third-party brands.
A clear expansion roadmap, including a proposed new manufacturing plant in Pithampur, Madhya Pradesh.
Scale-led financial profile, with FY26 revenue of about ₹1,163.9 crore and consolidated EBITDA of about ₹144.6 crore.
Exposure to both baby hygiene and adult care, which broadens the addressable market beyond a single age segment.
| Sr.no | Description | Date | File |
|---|---|---|---|
| 1 | Filed with SEBI/Exchange | 02/07/2026 | View DRHP |
IPO Lot Size
| Investors | No.of lots | Shares Offered | Max Bid Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 0 | 0 | 0 |
| Individual investors (Retail) (Max) | 0 | 0 | 0 |
| S-HNI (Min) | 0 | 0 | 0 |
| S-HNI (Max) | 0 | 0 | 0 |
| B-HNI (Min) | 0 | 0 | 0 |